| CSL Behring AG - Rhophylac 300, Injektionslösung |
| 53609 | | 02 | | Rhophylac 300 | | Injektionslösung | | J06BB01 | | Anti-D (Rh) Immunoglobulin | | 14.09.2001 | | |
|
| Composition |
| immunoglobulinum humanum anti-D 300 µg, proteina plasmatis humani, albuminum humanum, glycinum, natrii chloridum corresp. natrium max. 0.5 mmol, acidum aceticum, aqua ad iniectabile q.s. ad solutionem pro 2 ml. |
| Packungsbestandteile |
| Injection solution | | | | | | | | Active Agent | Dose |
|---|
| Immunoglobulinum Humanum Anti-D | 300µg / 2ml |
| | BAG: Active Agent | Dose |
|---|
| Immunoglobulinum Humanum Anti-D | 300 mcg |
| | | | Inactive agents |
|---|
| Acetic Acid | | Human Albumin | | Glycin | | Sodium Chloride | | Proteina Plasmatis Humani |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 023 | syringe(s) | 68.24 | 90.65 | B | SL | Yes |
|
